Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative analysis of molecular protocols for detecting pfhrp2 and pfhrp3 gene deletions in Plasmodium falciparum samples from Rondônia, Brazilian Amazon.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 extension statement: enhancing the reporting and usefulness of paediatric randomised trial protocols.

The Lancet. Child & adolescent health·2026
Same author

CONSORT-Children and Adolescents (CONSORT-C) 2026 extension statement: enhancing the reporting and impact of paediatric randomised trials.

The Lancet. Child & adolescent health·2026
Same author

Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK).

BMJ (Clinical research ed.)·2026
Same author

Co-creating care: Involving children, young people, and families in paediatric medical device innovation.

Frontiers in medicine·2026
Same author

SPIRIT-Children and Adolescents (SPIRIT-C) 2026 Extension Statement: Enhancing the Reporting and Usefulness of Pediatric Randomized Trial Protocols.

JAMA pediatrics·2026
Same journal

Different Clinical Questions Need Different Estimands.

Therapeutic innovation & regulatory science·2026
Same journal

Medicinal Chemistry Perspectives on Drug Repurposing: Innovative Approaches and Therapeutic Breakthrough.

Therapeutic innovation & regulatory science·2026
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Identifying and Deploying Benchmarks for Clinical Research at Sites.

Rida Momin1, Laura Mangiarini2, Alexandre Dias Tavares Costa3

  • 1Northern Care Alliance NHS Foundation Trust, Greater Manchester, UK. Rida.Momin@nca.nhs.uk.

Therapeutic Innovation & Regulatory Science
|June 23, 2026
PubMed
Summary
This summary is machine-generated.

A new benchmarking system was developed to address clinical trial site challenges. This scalable tool helps improve patient recruitment, protocol adherence, and regulatory compliance, supporting global research capacity development.

Keywords:
Clinical researchClinical research siteMetricsPerformance managementQuality management

More Related Videos

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Establishment of a Clinic-based Biorepository
07:50

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Area of Science:

  • Clinical research operations
  • Health services research
  • Biomedical informatics

Background:

  • Clinical trial sites face ongoing issues with patient recruitment, protocol adherence, and regulatory compliance.
  • Current methods for evaluating clinical trial site performance are often standardized, cumbersome, and lack adequate supporting tools.

Purpose of the Study:

  • To develop a standardized, adaptable, and globally applicable benchmarking system for clinical trial sites.
  • To create a digital tool that operationalizes identified benchmarks for diverse research settings.

Main Methods:

  • A three-phase study involving a scoping review of literature, a Delphi exercise with international experts, and the development of a digital tool.
  • Identification of 36 performance benchmarks from over 60 sources, organized into eight domains.
  • Consensus building through a two-round Delphi process involving experts from 9 countries across 4 continents.

Main Results:

  • 36 key performance benchmarks were identified and validated by international experts.
  • A digital tool integrating these benchmarks was developed, receiving positive initial user feedback for its utility and features like automated scoring.
  • The tool demonstrated perceived utility and acceptability, with features such as automated scoring and real-time performance feedback being positively received.

Conclusions:

  • The developed benchmarking system offers a scalable and adaptable framework to support the capacity development of clinical trial sites globally.
  • The tool aims to enhance the assessment and strengthening of clinical research capabilities worldwide.
  • Further real-world evaluation is recommended to confirm the impact of this system on operational and quality outcomes in clinical trials.